Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
Soligenix receives EU orphan drug designation for dusquetide in Behçet Disease, securing 10 years of market exclusivity. Phase 2a data demonstrated efficacy and safety. #Biotech #RareDiseases
2026-05-15T06:10:42.959Z